Organized by

28-30 September 2016 CLÍNICA UNIVERSIDAD DE NAVARRA

Sponsored by

CIMALAB

Scientific Committee Co-Chairs Ignacio Gil-Bazo, MD, PhD Ignacio Wistuba, MD Luis M. Montuenga, PhD Xabier Agirre, PhD María José Calasanz, PhD Ana Patiño, PhD Rubén Pío, PhD José Ignacio Echeveste, MD, PhD Mariano Ponz-Sarvisé, MD, PhD

+ Info Clínica Universidad de Navarra Pío XII, 36 Pamplona Navarra T +34 948 255 400 www.cun.es/area-profesionales/i-international-workshopgenomic-testing-cancer

I International Workshop on Genomic Testing in Cancer

I INTERNATIONAL WORKSHOP ON GENOMIC TESTING IN CANCER CLÍNICA UNIVERSIDAD DE NAVARRA

Program

Date

28-30 September 2016

Venue

CIMA. Center for Applied Medical Research of the Universidad of Navarra Avenida Pío XII, 55 31008 Pamplona. Navarra (Spain)

Wednesday September 28

Thursday September 29

Welcome 16:00 – 17:30 h.

Session II 8:30 - 11:30 h.

Session IV 15:00 - 18:00 h.

Session VI 8:30 - 10:00 h.

Hilario E. Mata Director, Global Academic Programs MD Anderson Cancer Center Houston. Ruth Vera Vice President, Sociedad Española de Oncología Médica. Jesús San Miguel Head of Clinical and Translational Medicine, Clínica Universidad de Navarra. Ignacio Wistuba Co-Chair, I International Workshop MD Anderson Cancer Center, USA. Ignacio Gil-Bazo Co-Chair, I International Workshop Clínica Universidad de Navarra, Spain.

Advances in Personalized Treatment of Cancer I

Genetic testing for the selection of patients for clinical trials

Practical Cases Discussion II

Registration

Carmen Lacosta [email protected] Registration Fee 300€ for professionals 150€ for residents or fellows

+ Info

T

Clínica Universidad de Navarra T 948 255 400 www.cun.es/area-profesionales/i-international-workshopgenomic-testing-cancer

his workshop aims to develop a theoretical and practical framework for the presentation of the most relevant and novel genetic approaches for the personalized diagnosis and treatment of cancer. In this workshop, relevant key opinion leaders will present the most updated strategies for cancer management, from immunotherapy to biomarkers, clinical trials and the standard of care of the most frequent solid malignancies.

O

riented to clinical oncologists and other medical professionals involved in cancer management, this workshop aims to be an update on the techniques and strategies, both at the laboratory and the clinical oncology setting. We are willing to receive you in Pamplona, for a fruitful learning based on clinical cases, presentations and discussion with leading experts in oncology at the I International Workshop on Genomic Testing in Cancer.

Keynote Session

Chairs Ignacio Wistuba Co-Chair, I International Workshop MD Anderson Cancer Center, USA Luis Montuenga Centro de Investigación Medica Aplicada, Spain Ignacio Gil-Bazo Clínica Universidad de Navarra, Spain Rafael Rosell Hospital Universitario Quirón Dexeus, Spain Genomic Testing as a Key Tool in Precision Medicine Coffee Break 17:30 - 18:00 h. Session I 18:00 – 20:00 h.

Different Techniques for Genomic Testing

Chairs Xabier Agirre Centro de Investigación Medica Aplicada, Spain Carlos de Andrea Universidad de Navarra, Spain Lola Lozano Clínica Universidad de Navarra, Spain Sample management: when the tissue is the issue Sara Álvarez NIMGenetics, Spain Cancer Genetics Ana Patiño Clínica Universidad de Navarra, Spain Molecular analysis & different techniques Welcome Cocktail 20:00 - 21:00 h.

Chairs Ignacio Gil-Bazo Clínica Universidad de Navarra, Spain Marta Santisteban Clínica Universidad de Navarra, Spain

Mariano Provencio Hospital Puerta de Hierro, Spain Lung Cancer as the Paradigm in Targeted Therapy Antonio González MD Anderson Cancer Center, Spain Genomic Testing in Breast and Ovarian Cancer Treatment Joaquim Bellmunt Dana-Farber Cancer Institute, USA Genomic Testing in Genitourinary Tumors Coffee Break 11:30 - 12:00 h. Session III 12:00 - 14:00 h.

Advances in Personalized Treatment of Cancer II Chairs Salvador Martín-Algarra Clínica Universidad de Navarra, Spain Javier Rodríguez Clínica Universidad de Navarra, Spain

Josep Tabernero Vall d’Hebron Institute of Oncology, Spain Improving Survival in Colorectal Cancer Therapy Ana Arance Hospital Clínic de Barcelona, Spain Advances in Targeted Therapy for Melanoma Lunch and poster session 14:00 - 15:00 h.

Friday September 30

Chairs Emiliano Calvo Centro Integral Oncológico Clara CampalSTART, Spain José Luis Pérez-Gracia Clínica Universidad de Navarra, Spain Ignacio Wistuba MD Anderson Cancer Center, USA Lessons learned from the BATTLEs Ignacio Melero Clínica Universidad de Navarra, Spain Next-Generation Sequencing-Guided Cancer Immunotherapy Jean-Charles Soria Institut Gustave Roussy, France Selection of patients for clinical trials according to the molecular profile Coffee Break 18:00 - 18:30 h. Session V 18:30-20:00 h.

Practical Cases Discussion I

Chairs Rubén Pío Centro de Investigación Médica Aplicada, Spain José I. Echeveste Clínica Universidad de Navarra, Spain Itziar Gardeazabal Clínica Universidad de Navarra, Spain Breast Cancer Antonio Calles Hospital Gregorio Marañón de Madrid, Spain Non-Small Cell Lung Cancer José Manuel Aramendía Clínica Universidad de Navarra, Spain Cervical Cancer Dinner for speakers 20:30 h.

Chairs Mariano Ponz-Sarvisé Clínica Universidad de Navarra, Spain Michel Idoate Clínica Universidad de Navarra, Spain Leyre Zubiri Clínica Universidad de Navarra, Spain Melanoma Guillen Argiles Vall d’Hebron Institute of Oncology, Spain Colorectal Cancer José María López-Picazo Clínica Universidad de Navarra, Spain Tumor of Unknown Origin Coffee Break 10:00 - 10:30 h. Session VII 10:30 - 13:30 h.

Future Perspectives: Ramón Areces Keynote Session

Chairs Christian Rolfo Antwerp University Hospital (UZA), Belgium Álvaro González Clínica Universidad de Navarra, Spain Ignacio Wistuba MD Anderson Cancer Center, USA Next generation sequencing in cancer: what’s next? Marileila Varella-García University of Colorado, USA Novel clinical applications of genomic testing in cancer María José Serrano Genyo, Spain The role of liquid biopsy in genomic testing in cancer Alan Nelson Visiongate, Inc. Phoenix, Arizona The predictive role of 3D structural biomarkers in cells from liquid biopsy: breast cancer in blood; lung cancer in sputum Closing remarks 13:30 – 13:45 h.